Shield & Care Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-12-2024
- Paid Up Capital ₹ 0.52 M
as on 27-12-2024
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 M
as on 27-12-2024
About Shield & Care Pharmaceuticals
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.52 M.
The company currently has active open charges totaling ₹5.50 M.
Gopal Bahurupi, Hemraj Kasulkar, and Kanhaiya Bahurupi serve as directors at the Company.
- CIN/LLPIN
U52520PN2022PTC214890
- Company No.
214890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2022
- Date of AGM
22 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shield & Care Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Bahurupi  | Director | 13-Dec-2022 | Current |
| Hemraj Kasulkar | Director | 20-Sep-2022 | Current |
| Kanhaiya Bahurupi | Director | 20-Sep-2022 | Current |
Financial Performance of Shield & Care Pharmaceuticals.
Enhance accessibility to Shield & Care Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shield & Care Pharmaceuticals?
Unlock access to Shield & Care Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sarvadnya Nucleus Hospital & Research Center Private LimitedActive 7 years 7 daysGopal Bahurupi is a mutual person
Charges (Loans)
₹5.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2024 | Others | ₹5.50 M | Open |
How Many Employees Work at Shield & Care Pharmaceuticals?
Shield & Care Pharmaceuticals has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shield & Care Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shield & Care Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.